Article Details
Retrieved on: 2021-10-20 06:33:09
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
19, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing ...
Article found on: www.wbko.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here